U.S. meningitis outbreak claims four more lives
15 states have reported meningitis infections as of Oct. 17, health officials announced Wednesday. / CBS
Four more deaths have been linked to a meningitis outbreak caused by contaminated steroid injections made by a specialty pharmacy, U.S. health officials announced Wednesday. That brings the nationwide total to 19 deaths.
A Centers for Disease Control and Prevention (CDC) update listed 247 reported infections in 15 states on its web site. The agency had previously reported 233 infected Americans including 15 deaths in 15 states.
Is meningitis in your state?
Two of the reported cases may be joint infections from steroid shots given in peripheral joints such as the knee, hip, shoulder and elbow. No deaths have been associated with peripheral joint infections, the CDC said.
One new death was reported in both Florida and Virginia, and two more deaths were reported in Tennessee, the state with the most reported infections with 61 cases.
The outbreak has been tied to methylprednisolone acetate steroid shots used for back pain made by a specialty pharmacy, New England Compounding Center, in Framingham, Mass. The center is currently under investigation by federal agencies.
Mass. pharmacy investigated for meningitis outbreak
FDA officials have said three potentially contaminated lots of the injections had over 17,000 vials in them. Up to 14,000 patients may have received the injections.
Officials have also reported infections in two people who got different drugs made by the company. One case is possible meningitis in a patient who got a spine injection of another type of steroid, triamcinolone acetonide. The agency also learned of one heart transplant patient who got fungal infections after being given a third company product, cardioplegia, during surgery.
- Lawmakers call for probe of meningitis-linked firm
- After 15 dead, feds search Mass. firm in meningitis case
- What contaminated the shots that spread meningitis?
Criminal investigators from the Food and Drug Administration have visited the New England Compounding Center.
FDA spokesman Steven Immergut said Tuesday the agents' work at the company is part of the investigation into the outbreak.
The Department of Justice confirmed Tuesday that it had opened an investigations into the NECC, but Massachusetts U.S. attorney Carmen Ortiz added it was "entirely premature to suggest what the results" would be.
Company attorney Paul Cirel says it's "difficult to understand the purpose" of the FDA search. He says the company has been clear it would voluntarily provide anything investigators requested. He says the company will continue to cooperate.
Popular in Health
- Disney pulls show that makes fun of gluten-free child
- Environmental Working Group's top sunscreens for 2013 12 Photos
- Which sunscreens are recommended for 2013?
- Skin cancer self-exam: What to look for (PHOTOS)
- Handbags may contain more germs than average toilet flush
- Ketamine shown to help fight treatment-resistant depression
- FDA raises concerns about experimental sleep aid suvorexant
- Doctor: Gel manicures a potential skin cancer risk
Why was the FDA excused from oversight of NECC? Who excused them?
Who was the NECC executive that was appointed head of Mass. State oversight agency? When did he serve? Who appointed him? Was NECC certifed by the state? Did the oversight agency run periodic quality audits of NECC. Did they have findings of anomalies? Did they follow up with acceptable corrective actions? Is this link between NECC and its oversight agency being investigated for criminal actions? The faster these questions can be accurately investigated and records sequestered, the sooner key evidence is prevented from destruction.---Charles
Thank you,
MFA
Box 1818
El Mirage AZ 85335
480 270 2652
World Meningitis Day 24 April 2013
www comoonline org
Educate~Vaccinate~Eradicate